RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated

Atsushi Tanabe, Kenya Tanikawa, Mai Tsunetomi, +9

Cancer Letters

Transcriptional RegulationRna Helicase Ythdc2MedicineRna BiologyCancer Cell Biology +8

Efficient Cross-Presentation by Heat Shock Protein 90-Peptide Complex-Loaded Dendritic Cells via an Endosomal Pathway

Takehiro Kurotaki, Yasuaki Tamura, G Ueda, +9

The Journal of Immunology

Peptide EngineeringImmunologyImmunoeditingMolecular BiologyImmunologic Mechanism +18

Human endoplasmic reticulum oxidoreductin 1‐α is a novel predictor for poor prognosis of breast cancer

Goro Kutomi, Yasuaki Tamura, Tsutomu Tanaka, +10

Cancer Science

Breast OncologyPathologyCancer BiologyRedox BiologyTumor Biology +14

Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy

Rena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe, +20

Clinical Cancer Research

Immunotherapeutic benefit of α‐interferon (IFNα) in survivin2<scp>B</scp>‐derived peptide vaccination for advanced pancreatic cancer patients

Hidekazu Kameshima, Tetsuhiro Tsuruma, Goro Kutomi, +12

Cancer Science

Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells

Jun Oura, Yoshifumi Tamura, Kenjiro Kamiguchi, +5

International Immunology

Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer

Tsutomu Tanaka, Goro Kutomi, Toshimitsu Kajiwara, +10

Oncotarget

ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway

Tadashi Ogawa, Yoshihiko Hirohashi, Aiko Murai, +17

Oncotarget

Biomedical ResearchCancer Stem CellPathologyCancer BiologyTumor Biology +21

Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level

Tsutomu Tanaka, Goro Kutomi, Toshimitsu Kajiwara, +10

British Journal of Cancer

Randomized phase <scp>II</scp> trial of survivin 2B peptide vaccination for patients with <scp>HLA</scp>‐A24‐positive pancreatic adenocarcinoma

Hiroaki Shima, Giichiro Tsurita, Satoshi Wada, +24

Cancer Science

Peptide VaccinationImmunodeficienciesVaccination TherapyImmunologyPathology +20